Синаптические процессы в околоводопроводном сером веществе мозга на модели болезни Паркинсона с протекцией гидрокортизоном
Автор: Овсепян М.Э., Погосян М.В., Саркисян Р.Ш., Даниелян М.А., Карапетян К.В., Ваградян А.Г., Симонян Л.Г., Минасян А.Л., Карамян Г.Г., Саркисян Д.С.
Журнал: Психология. Психофизиология @jpps-susu
Рубрика: Психофизиология
Статья в выпуске: 2 т.17, 2024 года.
Бесплатный доступ
Обоснование: при нейродегенеративных болезнях, в особенности при болезни Паркинсона(БП), поражаются антиноцицептивные центры, что сопровождается хронической болью. Поэтому является актуальным изыскание фармакологических препаратов, приводящих к протекции развитияБП и возможного купирования боли, связанного с БП.
Активность одиночных нейронов, высокочастотная стимуляция, синаптические ответы, ротеноновая модель болезни паркинсона, ротенон, болезнь паркинсона, околоводопроводное серое вещество мозга, большое ядро шва, гидрокортизон
Короткий адрес: https://sciup.org/147244044
IDR: 147244044 | DOI: 10.14529/jpps240208
Список литературы Синаптические процессы в околоводопроводном сером веществе мозга на модели болезни Паркинсона с протекцией гидрокортизоном
- Yi G., Wang Y., Wang L. et al. Capturing the Abnormal Brain Network Activity in Early Parkinsons Disease with Mild Cognitive Impairment based on Dynamic Functional Connectivity. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 2023;31;1238–1247. DOI: 10.1109/TNSRE.2023.3243035
- Broom D.M. Evolution of pain. In Pain: its nature and management in man and animals. Ed. Soulsby, Lord and Morton, D. Royal Society of Medicine International Congress Symposium Series. 2001;246:17–25.
- Walters E.T., de C Williams A.C. Evolution of mechanisms and behaviour important for pain. Philosophical Transactions of the Royal Society B. 2019;374(1785):20190275. DOI: 10.1098/rstb.2019.0275
- Nesse R.M., Schulkin J. An evolutionary medicine perspective on pain and its disorders. Philosophical Transactions of the Royal Society B. 2019;374(1785):20190288. DOI: 10.1098/rstb.2019.0288
- Strausfeld N.J., Hirth F. Introduction to Origin and evolution of the nervous system. Philosophical Transactions of the Royal Society B. 2015;370(1684):20150033. DOI: 10.1098/rstb.2015.0033
- Wenzel J.M., Oleson E.B., Gove W.N. et al. Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain. Current Biology. 2018;28(9):1392–1404.e5. DOI: 10.1016/j.cub.2018.03.037.
- Langston J.W. The Parkinsons complex: Parkinsonism is just the tip of the iceberg. Annals of Neurology. 2006;59:591–596. DOI: 10.1002/ana.20834
- Blanchet P.J., Brefel-Courbon C. Chronic pain and pain processing in Parkinsons disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2018;87(Pt.B):200–206. DOI: 10.1016/j.pnpbp.2017.10.010
- Antonini A., Tinazzi M., Abbruzzese G. et al. Pain in Parkinsons disease: facts and uncertainties. European Journal of Neurology. 2018;25(7):917–e969. DOI: 10.1111/ene.13624
- Nguy V., Barry B.K., Moloney N. et al. The associations between physical activity, sleep, and mood with pain in people with Parkinsons disease: an observational cross-sectional study. Journal of Parkinsons Disease. 2020;10:1161–1170. DOI: 10.3233/JPD-201938
- Brunner R., Gerberich A. Managing Pain in Parkinsons Disease. Practical Pain Manage-ment. 2021;21(1). URL: https://www.medcentral.com/neurology/parkinsons/managing-pain-parkinson-disease (accessed 24.11.2023)
- Gandolfi M., Geroin C., Antonini A. et al. Understanding and treating pain syndromes in Parkinsons disease. International Review of Neurobiology. 2017;134:827–858. DOI: 10.1016/bs.irn.2017.05.013
- Rukavina K., Leta V., Sportelli C. et al. Pain in Parkinsons disease: new concepts in path-ogenesis and treatment. Current Opinion in Neurology. 2019;32:579–588. DOI: 10.1097/WCO.0000000000000711
- Suppa A., Leone C., Di Stasio F. et al. Pain-motor integration in the primary motor cortex in Parkinsons disease. Brain Stimulation. 2017;10(4):806–816. DOI: 10.1016/j.brs.2017.04.130
- Sung S., Vijiaratnam N., Chan D.W.C. et al. Parkinson disease: A systemic review of pain sensitivities and its association with clinical pain and response to dopaminergic stimulation. Journal of the Neurological Sciences. 2018;395:172–206. DOI: 10.1016/j.jns.2018.10.013
- Joseph C., Jonsson-Lecapre J., Wicksell R. et al. Pain in persons with mild-moderate Parkinsons disease: a cross-sectional study of pain severity and associated factors. International Journal of Rehabilitation Research. 2019;42(4):371–376. DOI: 10.1097/MRR.0000000000000373
- Back F.P., Carobrez A.P. Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation. Neuropharmacology. 2018;135:399–411. DOI: 10.1016/j.neuropharm.2018.03.032
- Bourbia N., Pertovaara A. Involvement of the periaqueductal gray in the descending antinociceptive effect induced by the central nucleus of amygdala. Physiological Research. 2018;67(4):647–655. DOI: 10.33549/physiolres.933699
- Wang Q.P., Nakai Y. The dorsal raphe: an important nucleus in pain modulation. Brain Research Bulletin. 1994;34(6):575–585. DOI: 10.1016/0361-9230(94)90143-0
- Ham S., Lee Y.I., Jo M. et al. Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinsons disease model. Scientific Reports. 2017;7(1):525. DOI: 10.1038/s41598-017-00614-w
- Paxinos G., Watson C. The rat brain in stereotaxic coordinates. Elsevier. Academic Press. 2005:367.
- Kilkenny C., Browne W., Cuthill I.C. et al. Animal research: Reporting in vivo experiments: The ARRIVE guidelines. British Journal of Pharmacology. 2010;160(7):1577–1579. DOI: 10.1111/j.1476-5381.2010.00872.x
- Орлов А.И. Прикладная статистика. М.: Изд-во «Экзамен». 2004. 656 c.
- Hynd M.R., Scott H.L., Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimers disease. Neurochemistry International. 2004;45(5):583–595. DOI: 10.1016/j.neuint.2004.03.007.
- Lucas D.R., Newhouse J.P. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Archives of ophthalmology. 1957;58(2):193–201. DOI: 10.1001/archopht.1957.00940010205006.
- Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164(3880):719–721. DOI: 10.1126/science.164.3880.719.
Статья научная
